Top Markets
#1 TENDIES TENDIES +53.98%
#2 Cash Cat Cash Cat +24.80%
#3 OSK OSK +15.39%
#4 龙虾 (Lobster) 龙虾 (Lobster) +11.92%
#5 Ardor Ardor +7.13%
#6 Tornado Cash Tornado Cash +6.57%
#7 UnifAI Network UnifAI Network +6.46%
#8 Zora Zora +6.31%
#9 Nesa Nesa +5.84%
#10 Talus Network Talus Network +5.47%
Coin of the day
TENDIES TENDIES
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Classement en actions #16729
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Prix de l'action
$3.78
Dernière synchronisation: 2026-03-17
Capitalisation boursière
$276.54M
Changement (1 jour)
0.00%
Changement (1 an)
45.53%
Pays
CA
Échange NervGen Pharma Corp. (NGEN)

Catégorie

Healthcare
Le prix NGEN avec la capitalisation boursière de B
NervGen Pharma Corp. NervGen Pharma Corp.
NGEN
$3.78
Capitalisation boursière de NervGen Pharma Corp.(NGEN)
Capitalisation boursière: $276.54M
En September 2026, NervGen Pharma Corp. a une capitalisation boursière de $276.54M. Cela fait de NervGen Pharma Corp. la 16729th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de NervGen Pharma Corp. du 2019 au 2026
NGEN par rapport au top 5 des plus populaires stocks
Prix pour NGEN L’actif B La capitalisation boursière de B Résultats
NervGen Pharma Corp. NervGen Pharma Corp.
$71,888.99 $276.54M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.260T +1,901,838.46%
NervGen Pharma Corp. NervGen Pharma Corp.
$65,313.56 $276.54M
Apple Inc. Apple Inc.
AAPL
$4.779T +1,727,874.76%
NervGen Pharma Corp. NervGen Pharma Corp.
$54,901.31 $276.54M
Alphabet Inc. Alphabet Inc.
GOOG
$4.017T +1,452,402.14%
NervGen Pharma Corp. NervGen Pharma Corp.
$50,835.98 $276.54M
Microsoft Corporation Microsoft Corporation
MSFT
$3.719T +1,344,847.31%
NervGen Pharma Corp. NervGen Pharma Corp.
$37,371.93 $276.54M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.734T +988,634.15%